2.0
30. Okt. 2011
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
La Jolla, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
In the Research realm, the resources and scientific capabilties were extraordinary. At the La Jolla site, the legacy of scientific integrity survived for a number of years beyond the acquisition by Pfizer but suffered in recent years.
Kontras
The quality of the decision-making at the site governance and global leadership levels was abysmal. New strategies were paraded out with great fanfare and then abandoned within a year or two simply because a new guy took over at the top.